Resistance factor | Product | Antibiotic class | Mortality (% of cows infected by positive strains) | Bacteriological cure | Clinical cure | Loss of mammary quarter function. | Reoccurrence of CM | Total of positive strains | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dead | Alive | No | Yes | No | Yes | No | Yes | No | Yes | ||||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | ||||
rlmA(II) | 23 S rRNA (guanine(748)-N(1))-methyltransferase | Macrolides, Lincosamides | 31 | 19 | 28 | 81 | 88 | 55 | 71 | 45 | 20 | 13 | 139 | 87 | 142 | 89 | 17 | 11 | 121 | 76 | 38 | 24 | 159 |
rpoB | DNA-directed RNA polymerase beta subunit | Rifamycins, Peptide antibiotics | 31 | 19 | 128 | 81 | 88 | 55 | 71 | 45 | 20 | 13 | 139 | 87 | 142 | 89 | 17 | 11 | 121 | 76 | 38 | 24 | 159 |
rpoC | DNA-directed RNA polymerase beta’ subunit | Myxopyronins Corallopyronins, Peptide antibiotics | 31 | 19 | 128 | 81 | 88 | 55 | 71 | 45 | 20 | 13 | 139 | 87 | 142 | 89 | 17 | 11 | 121 | 76 | 38 | 24 | 159 |
S10p | SSU ribosomal protein S10p | Tetracyclines, Glycylcyclines | 30 | 19 | 128 | 81 | 87 | 55 | 71 | 45 | 20 | 13 | 138 | 87 | 141 | 89 | 17 | 11 | 120 | 76 | 38 | 24 | 158 |
alr | Alanine racemase | Cycloserine | 31 | 20 | 126 | 80 | 86 | 55 | 71 | 45 | 20 | 13 | 137 | 87 | 140 | 89 | 17 | 11 | 119 | 76 | 38 | 24 | 157 |
EF-G | Translation elongation factor G | Fusidic acid | 31 | 20 | 126 | 80 | 87 | 55 | 70 | 45 | 20 | 13 | 137 | 87 | 140 | 89 | 17 | 11 | 119 | 76 | 38 | 24 | 157 |
S12p | SSU ribosomal protein S12p | Aminoglycosides | 31 | 20 | 126 | 80 | 87 | 55 | 70 | 45 | 20 | 13 | 137 | 87 | 140 | 89 | 17 | 11 | 119 | 76 | 38 | 24 | 157 |
pgsA | CDP-diacylglycerol–glycerol-3-phosphate 3-phosphatidyltransferase | Peptide antibiotics (daptomycin) | 28 | 18 | 127 | 82 | 85 | 55 | 70 | 45 | 20 | 13 | 135 | 87 | 138 | 89 | 17 | 11 | 121 | 78 | 34 | 22 | 155 |
fabK | Enoyl-[acyl-carrier-protein] reductase [FMN, NADH] | Triclosan | 30 | 19 | 124 | 81 | 84 | 55 | 70 | 45 | 20 | 13 | 134 | 87 | 138 | 90 | 16 | 10 | 116 | 75 | 38 | 25 | 154 |
kasA | 3-oxoacyl-[acyl-carrier-protein] synthase, KASII | Isoniazid, Triclosan | 30 | 19 | 124 | 81 | 84 | 55 | 70 | 45 | 20 | 13 | 134 | 87 | 138 | 90 | 16 | 10 | 116 | 75 | 38 | 25 | 154 |
D | Lincosamide nucleotidyltransferase = > Lnu(D) | Lincosamides | 30 | 20 | 122 | 80 | 83 | 55 | 69 | 45 | 20 | 13 | 132 | 87 | 135 | 89 | 17 | 11 | 114 | 75 | 38 | 25 | 152 |
liaF | Membrane protein LiaF(VraT), specific inhibitor of LiaRS(VraRS) signaling pathway | Peptide antibiotics (daptomycin) | 30 | 20 | 121 | 80 | 84 | 56 | 67 | 44 | 20 | 13 | 131 | 87 | 134 | 89 | 17 | 11 | 113 | 75 | 38 | 25 | 151 |
LiaR | Cell envelope stress response system LiaFSR, response regulator LiaR(VraR) | Peptide antibiotics (daptomycin) | 30 | 20 | 121 | 80 | 84 | 56 | 67 | 44 | 20 | 13 | 131 | 87 | 134 | 89 | 17 | 11 | 113 | 75 | 38 | 25 | 151 |
LiaS | Cell envelope stress response system LiaFSR, sensor histidine kinase LiaS(VraS) | Peptide antibiotics (daptomycin) | 30 | 20 | 121 | 80 | 84 | 56 | 67 | 44 | 20 | 13 | 131 | 87 | 134 | 89 | 17 | 11 | 113 | 75 | 38 | 25 | 151 |
murA | UDP-N-acetylglucosamine 1-carboxyvinyltransferase | Fosfomycin | 30 | 20 | 121 | 80 | 84 | 56 | 67 | 44 | 20 | 13 | 131 | 87 | 134 | 89 | 17 | 11 | 113 | 75 | 38 | 25 | 151 |
gidB | 16 S rRNA (guanine(527)-N(7))-methyltransferase | Aminoglycosides | 29 | 19 | 121 | 81 | 83 | 55 | 67 | 45 | 20 | 13 | 130 | 87 | 133 | 89 | 17 | 11 | 112 | 75 | 38 | 25 | 150 |
GdpD | Glycerophosphoryl diester phosphodiesterase | Peptide antibiotics (daptomycin) | 30 | 20 | 119 | 80 | 83 | 56 | 66 | 44 | 20 | 13 | 129 | 87 | 132 | 89 | 17 | 11 | 111 | 74 | 38 | 26 | 149 |
folP | Dihydropteroate synthase | Sulfonamides | 30 | 20 | 117 | 80 | 84 | 57 | 63 | 43 | 20 | 14 | 127 | 86 | 131 | 89 | 16 | 11 | 109 | 74 | 38 | 26 | 147 |
ddl | D-alanine–D-alanine ligase | Cycloserine | 29 | 20 | 117 | 80 | 81 | 55 | 65 | 45 | 20 | 14 | 126 | 86 | 129 | 88 | 17 | 12 | 108 | 74 | 38 | 26 | 146 |
Iso-tRNA | Isoleucyl-tRNA synthetase | Mupirocin | 30 | 21 | 116 | 79 | 83 | 57 | 63 | 43 | 20 | 14 | 126 | 86 | 130 | 89 | 16 | 11 | 109 | 75 | 37 | 25 | 146 |
folA, Dfr | Dihydrofolate reductase | Diaminopyrimidines | 29 | 20 | 115 | 80 | 81 | 56 | 63 | 44 | 20 | 14 | 124 | 86 | 128 | 89 | 16 | 11 | 107 | 74 | 37 | 26 | 144 |
gyrB | DNA gyrase subunit B | Novobiocin | 29 | 20 | 115 | 80 | 80 | 56 | 64 | 44 | 20 | 14 | 124 | 86 | 127 | 88 | 17 | 12 | 106 | 74 | 38 | 26 | 144 |
gyrA | DNA gyrase subunit A | Ciprofloxacin | 30 | 21 | 113 | 79 | 80 | 56 | 63 | 44 | 20 | 14 | 123 | 86 | 127 | 89 | 16 | 11 | 106 | 74 | 37 | 26 | 143 |
EF-Tu | Translation elongation factor Tu | Elfamycins | 29 | 21 | 112 | 79 | 77 | 55 | 64 | 45 | 20 | 14 | 121 | 86 | 127 | 90 | 14 | 10 | 105 | 74 | 36 | 26 | 141 |
tetM | Tetracycline resistance, ribosomal protection type = > Tet(M) | Tetracyclines | 6 | 13 | 42 | 88 | 20 | 42 | 28 | 58 | 6 | 13 | 42 | 88 | 43 | 90 | 5 | 10 | 39 | 81 | 9 | 19 | 48 |
parC | DNA topoisomerase IV subunit A | Ciprofloxacin | 0 | 00 | 7 | 100 | 4 | 57 | 3 | 43 | 2 | 29 | 5 | 71 | 6 | 86 | 1 | 14 | 7 | 100 | 0 | 00 | 7 |
ant (6)-I | Aminoglycoside 6-nucleotidyltransferase | Aminoglycosides | 1 | 25 | 3 | 75 | 1 | 25 | 3 | 75 | 0 | 00 | 4 | 100 | 4 | 100 | 0 | 00 | 4 | 100 | 0 | 00 | 4 |
bceR | Two-component response regulator BceR | Peptide antibiotics (bacitracin) | 1 | 50 | 1 | 50 | 1 | 50 | 1 | 50 | 0 | 00 | 2 | 100 | 2 | 100 | 0 | 00 | 1 | 50 | 1 | 50 | 2 |
lsa(E) | ABC-F type ribosomal protection protein | Lincosamides | 0 | 00 | 1 | 100 | 0 | 00 | 1 | 100 | 0 | 00 | 1 | 100 | 1 | 100 | 0 | 00 | 1 | 100 | 0 | 00 | 1 |